Skip to main content
DNA Labs India

Liquid Biopsy 117 Gene Panel Test

DNA Labs India | ISO 9001:2015 Certified

Liquid Biopsy 117 Gene Panel Test

Also known as: 117 Gene Panel Liquid Biopsy, ctDNA 117 Gene Panel, Liquid Biopsy Cancer Panel

Liquid Biopsy 117 Gene Panel Test test available at DNA Labs India for ₹33,000. Uses Next-Generation Sequencing (NGS) on Blood samples. Results in Reports are available within 25 working days.. Free home collection in 300+ cities across India.

Liquid BiopsyAdult🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the Liquid Biopsy 117 Gene Panel is to detect circulating tumor DNA (ctDNA) and identify actionable mutations that guide targeted therapy, monitor treatment response, and detect minimal residual disease. It helps oncologists make informed decisions about personalized treatment plans, including the use of targeted therapies and immunotherapies. Additionally, it can be used for early cancer detection in high-risk individuals and for tracking tumor evolution over time.

Test Code
6112
CPT Code
81479
ICD Code
Z12.9
Price
₹33,000
Sample Type
Blood
Result Time
Reports are available within 25 working days.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation required. A doctor's prescription is recommended. Inform your doctor about any medications you are taking.

Method: Venipuncture

Step 2

Laboratory Analysis

A blood sample will be drawn from a vein in your arm. The procedure is quick and minimally invasive.

Step 3

Report Delivery

You may resume normal activities immediately. There are no restrictions after the test.

Timeline: Reports are available within 25 working days.

Patient Instructions

1
Before the Test:No special preparation required. A doctor's prescription is recommended.
2
During the Test:A blood sample will be drawn from a vein in your arm.
3
After the Test:You may resume normal activities immediately.

About This Test

Who Should Get This Test

The purpose of the Liquid Biopsy 117 Gene Panel is to detect circulating tumor DNA (ctDNA) and identify actionable mutations that guide targeted therapy, monitor treatment response, and detect minimal residual disease. It helps oncologists make informed decisions about personalized treatment plans, including the use of targeted therapies and immunotherapies. Additionally, it can be used for early cancer detection in high-risk individuals and for tracking tumor evolution over time.

How to Prepare

  • Use Streck tube (black top) for sample collection.
  • Ensure proper mixing of blood with preservative by inverting tube 8-10 times.
  • Do not refrigerate or freeze the sample.
  • Transport sample at ambient temperature to the laboratory within 24 hours.

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Liquid biopsy is a breakthrough for cancer management, offering a non-invasive method to detect mutations and monitor treatment response. This 117-gene panel provides comprehensive coverage of actionable genes, aiding in personalized therapy decisions."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood
Sample Volume10 mL
ContainerStreck Tube (Black Top)
Collection MethodVenipuncture

Sample Stability

Ambient temperature: 7 days
Refrigerated: Not recommended
Frozen: Not recommended
Sample Rejection Criteria:
  • Clotted sample
  • Hemolyzed sample
  • Incorrect tube
  • Insufficient volume
  • Sample received after prolonged delay

Understanding Your Results

The Liquid Biopsy 117 Gene Panel report identifies mutations in circulating tumor DNA. The presence of specific mutations may indicate cancer and guide targeted therapy. Absence of mutations does not rule out cancer.
Positive for a mutation: Indicates presence of ctDNA with that alteration. Clinical correlation required.
Negative for mutations: No detectable mutations in the analyzed genes. May be due to low ctDNA or absence of these mutations.
Variant of unknown significance (VUS): A genetic change with unclear clinical impact. Further analysis may be needed.
⚠️ When to Consult a Doctor:

Consult your oncologist or healthcare provider to discuss the results and their implications for your treatment plan.

Limitations

  • Only specific hotspots are covered for TP53 and other genes; full gene sequencing is not performed.
  • May not detect all types of cancer or all mutations.
  • Results should be interpreted in conjunction with clinical findings.
  • Not intended for screening the general population.
  • May not be informative if ctDNA levels are below detection limit.

Risks & Considerations

  • Minimal risk of bleeding or bruising at the puncture site.
  • Rare risk of infection.
  • Fainting or dizziness during blood draw.

Interfering Factors

  • Recent blood transfusion may dilute ctDNA.
  • Clotting of sample due to improper mixing.
  • Insufficient blood volume.
  • Sample hemolysis.
  • Presence of benign clonal hematopoiesis may cause false positives.

Compare With Similar Tests

TestLiquid Biopsy 117 Gene PanelTissue BiopsySingle Gene Mutation TestCTC Test
ComparisonLiquid Biopsy 117 Gene Panel

Frequently Asked Questions

What is the Liquid Biopsy 117 Gene Panel?
It is a non-invasive blood test that analyzes 117 genes associated with cancer to detect mutations in circulating tumor DNA (ctDNA).
How is the test performed?
A simple blood sample is drawn from a vein, collected in a Streck tube, and sent to the lab for NGS analysis.
What is the cost of the test?
The test costs INR 33000 at DNA Labs India.
Is fasting required before the test?
No, fasting is not required.
What is the turnaround time for results?
Results are available within 25 working days.
Can this test detect all types of cancer?
It can detect mutations in 117 genes commonly associated with many cancers, but not all cancer types or mutations.
Is the test covered by insurance?
Coverage varies by insurance plan. Please check with your provider.
Do I need a doctor's prescription?
Yes, a doctor's prescription is recommended for this test.
Is home sample collection available?
Yes, we offer free home sample collection for online bookings across India.
What is the sample type required?
Blood sample in a Streck tube (black top).
Are there any risks associated with the test?
The test is minimally invasive with rare risks like bruising or infection at the puncture site.
How should I interpret my results?
Results should be interpreted by your oncologist, who will correlate them with your clinical condition.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.